Mutated genes for the catalytic protein of oplophorus luciferase and use thereof
Secreted luciferases which are different from those known heretofore have been desired. The present invention provides a luciferase mutant comprising an amino acid sequence in which at least one amino acid selected from amino acids at the positions of 1 to 4 is deleted in the amino acid sequence of SEQ ID NO: 2.
1. A luciferase mutant selected from (a) to (d) below:
(a) a luciferase mutant consisting of an amino acid sequence in which at least one amino acid selected from amino acids at the positions of 1 to 4 is deleted in the amino acid sequence of SEQ ID NO: 2;
(b) a luciferase mutant consisting of an amino acid sequence in which at least one amino acid selected from amino acids at the positions of 1 to 4 is deleted in the amino acid sequence of SEQ ID NO: 2 and an amino acid sequence excluding the amino acids at the positions of 1 to 4 is an amino acid sequence in which 1 to 17 amino acids are deleted, substituted, inserted and/or added in the amino acid sequence at the positions of 5 to 169 of SEQ ID NO: 2, and having a luciferase activity;
(c) a luciferase mutant consisting of an amino acid sequence in which at least one amino acid selected from amino acids at the positions of 1 to 4 is deleted in the amino acid sequence of SEQ ID NO: 2 and an amino acid sequence excluding the amino acids at the positions of 1 to 4 has at least 90% identity to the amino acid sequence at the positions of 5 to 169 of SEQ ID NO: 2, and having a luciferase activity; and,
(d) a luciferase mutant consisting of an amino acid sequence in which at least one amino acid selected from amino acids at the positions of 1 to 4 is deleted in the amino acid sequence of SEQ ID NO: 2 and an amino acid sequence excluding the amino acids at the positions of 1 to 4 is encoded by a polynucleotide which hybridizes under stringent conditions to a polynucleotide consisting of a nucleotide sequence complementary to a nucleotide sequence encoding the amino acid sequence at the positions of 5 to 169 of SEQ ID NO: 2, wherein the high stringency conditions are 5 × SSC, 5 × Denhardt's solution, 0.5% (w/v) SDS, 50% (v/v) formamide, and 50° C., and having a luciferase activity.
2. The luciferase mutant according to claim 1 , wherein the luciferase mutants defined in (b) to (d) above are mutants defined in (b-1) to (d-1) below:
(b-1) a luciferase mutant consisting of an amino acid sequence in which at least one amino acid selected from amino acids at the positions of 1 to 4 is deleted in the amino acid sequence of SEQ ID NO: 2 and an amino acid sequence excluding the amino acids at the positions of 1 to 4 is an amino acid sequence in which 1 to 9 amino acids are deleted, substituted, inserted and/or added in the amino acid sequence at the positions of 5 to 169 of SEQ ID NO: 2, and having a luciferase activity;
(c-1) a luciferase mutant consisting of an amino acid sequence in which at least one amino acid selected from amino acids at the positions of 1 to 4 is deleted in the amino acid sequence of SEQ ID NO: 2 and an amino acid sequence excluding the amino acids at the positions of 1 to 4 has at least 95% identity to the amino acid sequence at the positions of 5 to 169 of SEQ ID NO: 2, and having a luciferase activity; and,
(d-1) a luciferase mutant consisting of an amino acid sequence in which at least one amino acid selected from amino acids at the positions of 1 to 4 is deleted in the amino acid sequence of SEQ ID NO: 2 and an amino acid sequence excluding the amino acids at the positions of 1 to 4 is encoded by a polynucleotide which hybridizes under high stringent conditions to a polynucleotide consisting of a nucleotide sequence complementary to a nucleotide sequence encoding the amino acid sequence at the positions of 5 to 169 of SEQ ID NO: 2, wherein the high stringency conditions are 5 × SC, 5 × Denhardt's solution, 0.5% (w/v) SDS, 50% (v/v) formamide, and 50° C., and having a luciferase activity.
3. A luciferase mutant consisting of an amino acid sequence selected from SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8 and SEQ ID NO: 10.
4. A kit comprising the luciferase mutant according to claim 1 .
5. The kit according to claim 4 , further comprising a luciferin.
6. The kit according to claim 5 , wherein the luciferin is coelenterazines.
7. The kit according to claim 6 , wherein the coelenterazines is bis-coelenterazine or 6h-f-coelenterazine.
8. A kit comprising the luciferase mutant according to claim 2 .
9. The kit according to claim 8 , further comprising a luciferin.
10. The kit according to claim 9 , wherein the luciferin is coelenterazines.
11. The kit according to claim 10 , wherein the coelenterazines is bis-coelenterazine or 6h-f-coelenterazine.
12. A kit comprising the luciferase mutant according to claim 3 .
13. The kit according to claim 12 , further comprising a luciferin.
14. The kit according to claim 13 , wherein the luciferin is coelenterazines.
15. The kit according to claim 14 , wherein the coelenterazines is bis-coelenterazine or 6h-f-coelenterazine.